These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17320140)

  • 1. Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome.
    Tripathi S; Chaubey B; Barton BE; Pandey VN
    Virology; 2007 Jun; 363(1):91-103. PubMed ID: 17320140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.
    Ganguly S; Chaubey B; Tripathi S; Upadhyay A; Neti PV; Howell RW; Pandey VN
    Oligonucleotides; 2008 Sep; 18(3):277-86. PubMed ID: 18729823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N; Basu A; Pandey VN
    Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNA targeting the PBS and A-loop sequences of HIV-1 genome destabilizes packaged tRNA3(Lys) in the virions and inhibits HIV-1 replication.
    Kaushik N; Pandey VN
    Virology; 2002 Nov; 303(2):297-308. PubMed ID: 12490391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient biodelivery system for antisense polyamide nucleic acid (PNA).
    Mehiri M; Upert G; Tripathi S; Di Giorgio A; Condom R; Pandey VN; Patino N
    Oligonucleotides; 2008 Sep; 18(3):245-56. PubMed ID: 18707540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
    Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
    Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.
    Upadhyay A; Ponzio NM; Pandey VN
    Oligonucleotides; 2008 Dec; 18(4):329-35. PubMed ID: 19006449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog.
    Kaushik N; Talele TT; Monel R; Palumbo P; Pandey VN
    Nucleic Acids Res; 2001 Dec; 29(24):5099-106. PubMed ID: 11812842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties.
    Chaubey B; Tripathi S; Ganguly S; Harris D; Casale RA; Pandey VN
    Virology; 2005 Jan; 331(2):418-28. PubMed ID: 15629784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
    Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
    J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome.
    Beerens N; Klaver B; Berkhout B
    J Virol; 2000 Mar; 74(5):2227-38. PubMed ID: 10666253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.
    Turpin JA; Buckheit RW; Derse D; Hollingshead M; Williamson K; Palamone C; Osterling MC; Hill SA; Graham L; Schaeffer CA; Bu M; Huang M; Cholody WM; Michejda CJ; Rice WG
    Antimicrob Agents Chemother; 1998 Mar; 42(3):487-94. PubMed ID: 9517921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.
    Das I; Désiré J; Manvar D; Baussanne I; Pandey VN; Décout JL
    J Med Chem; 2012 Jul; 55(13):6021-32. PubMed ID: 22698070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.